Company / Current Assets
Arcus Biosciences, Inc. Current Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.0B
FY2025
5-year range
$831.0M / $1.3B
FY2021-FY2025
Trend
-0.9%
vs FY2024
Sector context
#49 of 213
Health Care
What the data says
Arcus Biosciences, Inc.'s current assets of $1.0B is higher than 77% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 9 years, ranging from $177M in FY2017 to $1.3B in FY2021.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +6.5%. Top quartile in the Health Care sector.
Improved from $831M to $1.0B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Sector benchmark
-60.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.5%, indicating consistent growth.
- In FY2025, current assets decreased 0.9% year-over-year.
- Ranks #49 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | -0.9% |
| FY2024 | $1.0B | +22.3% |
| FY2023 | $831.0M | -22.1% |
| FY2022 | $1.1B | -15.5% |
| FY2021 | $1.3B | +71.5% |
| FY2020 | $735.8M | +281.8% |
| FY2019 | $192.7M | -25.6% |
| FY2018 | $258.9M | +46.4% |
| FY2017 | $176.9M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026